Stanford Trial Tests Remote CGM Monitoring to Transform Early Type 1 Diabetes Care — Digital Health Integration Study

References

1. 1.Addala, A., Auzanneau, M., Miller, K., Maier, W., Foster, N., Kapellen, T., ... & Maahs, D. M. (2021). A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: A transatlantic comparison. Diabetes Care, 44(1), 133-140. https://doi.org/10.2337/dc20-2257
2. 2.Australian Government Department of Health. (2022). Pharmaceutical Benefits Scheme: Continuous Glucose Monitoring. PBS. https://www.pbs.gov.au/
3. 3.Cameron, F. J., Scratch, S. E., Nadebaum, C., Northam, E. A., Koves, I., Jennings, J., ... & Davis, E. A. (2013). Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children. Diabetes Care, 36(6), 1638-1644. https://doi.org/10.2337/dc12-1904
4. 4.Dabelea, D., Rewers, A., Stafford, J. M., Standiford, D. A., Lawrence, J. M., Saydah, S., ... & Pihoker, C. (2014). Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics, 133(4), e938-e945. https://doi.org/10.1542/peds.2013-2795
5. 5.Messer, L. H., Forlenza, G. P., Sherr, J. L., Wadwa, R. P., Buckingham, B. A., Weinzimer, S. A., ... & Maahs, D. M. (2018). Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the MiniMed 670G system. Diabetes Care, 41(4), 789-796. https://doi.org/10.2337/dc17-2682
6. 6.Prahalad, P., Tanenbaum, M., Hood, K., & Maahs, D. M. (2018). Diabetes technology: improving care, improving patient-reported outcomes and preventing complications in young people with Type 1 diabetes. Diabetic Medicine, 35(4), 419-429. https://doi.org/10.1111/dme.13588
7. 7.Sherr, J. L., Hermann, J. M., Campbell, F., Foster, N. C., Hofer, S. E., Allgrove, J., ... & Warner, J. T. (2020). Use of insulin degludec in children and adolescents with type 1 diabetes: An international comparative effectiveness study. Diabetes Care, 43(10), 2288-2296. https://doi.org/10.2337/dc19-1214
8. 8.Stanford University. (2024). The Use of Continuous Glucose Monitor Technology and Remote Monitoring to Change Clinical Outcomes Following New Diagnosis of Type 1 Diabetes in the Pediatric Population. ClinicalTrials.gov. NCT03968055. https://clinicaltrials.gov/study/NCT03968055